-
Something wrong with this record ?
Adherence to application technique of inhaled corticosteroid in patients with asthma and COVID-19 improves outcomes
A. Tichopád, J. Žigmond, M. Jeseňák, I. Solovič, K. Breciková, M. Rybář, M. Rožánek, V. Sedlák
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2014
Free Medical Journals
from 2013
PubMed Central
from 2013
Europe PubMed Central
from 2013
ProQuest Central
from 2013-01-01
Open Access Digital Library
from 2013-01-01
Open Access Digital Library
from 2014-01-01
Health & Medicine (ProQuest)
from 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2013
- MeSH
- Asthma * drug therapy MeSH
- COVID-19 * MeSH
- Adrenal Cortex Hormones MeSH
- Quality of Life MeSH
- Humans MeSH
- Forced Expiratory Volume MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: Inhaled corticosteroids have been widely reported as a preventive measure against the development of severe forms of COVID-19 not only in patients with asthma. METHODS: In 654 Czech and Slovak patients with asthma who developed COVID-19, we investigated whether the correct use of inhaler containing corticosteroids was associated with a less severe course of COVID-19 and whether this had an impact on the need for hospitalisation, measurable lung functions and quality of life (QoL). RESULTS: Of the studied cohort 51.4% had moderate persistent, 29.9% mild persistent and 7.2% severe persistent asthma. We found a significant adverse effect of poor inhaler adherence on COVID-19 severity (p=0.049). We also observed a lower hospitalisation rate in patients adequately taking the inhaler with OR of 0.83. Vital capacity and forced expiratory lung volume deterioration caused by COVID-19 were significantly reversed, by approximately twofold to threefold, in individuals who inhaled correctly. CONCLUSION: Higher quality of inhalation technique of corticosteroids measured by adherence to an inhaled medication application technique (A-AppIT) score had a significant positive effect on reversal of the vital capacity and forced expiratory lung volume in 1 s worsening (p=0.027 and p<0.0001, respectively) due to COVID-19. Scoring higher in the A-AppIT was also associated with significantly improved QoL. All measured variables concordantly and without exception showed a positive improvement in response to better adherence. We suggest that corticosteroids provide protection against the worsening of lungs in patients with COVID-19 and that correct and easily assessable adherence to corticosteroids with appropriate inhalation technique play an important role in preventing severe form of COVID-19.
CEEOR spol s r o Prague Czech Republic
Department of Respiratory Medicine Fakultní Nemocnice Hradec Králové Hradec Králové Czech Republic
Faculty of Health Catholic University in Ruzomberok Ruzomberok Slovakia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007640
- 003
- CZ-PrNML
- 005
- 20241127145556.0
- 007
- ta
- 008
- 240412s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/bmjresp-2023-001874 $2 doi
- 035 __
- $a (PubMed)38184317
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Tichopád, Aleš $u Department of Biomedical Technology, Czech Technical University in Prague Faculty of Biomedical Engineering, Kladno, Czech Republic $1 https://orcid.org/0000000213080877 $7 xx0305052
- 245 10
- $a Adherence to application technique of inhaled corticosteroid in patients with asthma and COVID-19 improves outcomes / $c A. Tichopád, J. Žigmond, M. Jeseňák, I. Solovič, K. Breciková, M. Rybář, M. Rožánek, V. Sedlák
- 520 9_
- $a BACKGROUND: Inhaled corticosteroids have been widely reported as a preventive measure against the development of severe forms of COVID-19 not only in patients with asthma. METHODS: In 654 Czech and Slovak patients with asthma who developed COVID-19, we investigated whether the correct use of inhaler containing corticosteroids was associated with a less severe course of COVID-19 and whether this had an impact on the need for hospitalisation, measurable lung functions and quality of life (QoL). RESULTS: Of the studied cohort 51.4% had moderate persistent, 29.9% mild persistent and 7.2% severe persistent asthma. We found a significant adverse effect of poor inhaler adherence on COVID-19 severity (p=0.049). We also observed a lower hospitalisation rate in patients adequately taking the inhaler with OR of 0.83. Vital capacity and forced expiratory lung volume deterioration caused by COVID-19 were significantly reversed, by approximately twofold to threefold, in individuals who inhaled correctly. CONCLUSION: Higher quality of inhalation technique of corticosteroids measured by adherence to an inhaled medication application technique (A-AppIT) score had a significant positive effect on reversal of the vital capacity and forced expiratory lung volume in 1 s worsening (p=0.027 and p<0.0001, respectively) due to COVID-19. Scoring higher in the A-AppIT was also associated with significantly improved QoL. All measured variables concordantly and without exception showed a positive improvement in response to better adherence. We suggest that corticosteroids provide protection against the worsening of lungs in patients with COVID-19 and that correct and easily assessable adherence to corticosteroids with appropriate inhalation technique play an important role in preventing severe form of COVID-19.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kvalita života $7 D011788
- 650 12
- $a COVID-19 $7 D000086382
- 650 12
- $a bronchiální astma $x farmakoterapie $7 D001249
- 650 _2
- $a hormony kůry nadledvin $7 D000305
- 650 _2
- $a usilovný výdechový objem $7 D005541
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Žigmond, Jan $u Department of Biomedical Technology, Czech Technical University in Prague Faculty of Biomedical Engineering, Kladno, Czech Republic
- 700 1_
- $a Jeseňák, Miloš $u Department of Pulmonology and Phthisiology, Comenius University in Bratislava Jessenius Faculty of Medicine in Martin, Martin, Slovakia
- 700 1_
- $a Solovič, Ivan $u National Institute of Tuberculosis, Lung Diseases and Thoracic Surgery, Vyšné Hágy, Slovakia, Vyšné Hágy, Slovakia, Vyšné Hágy, Slovakia $u Faculty of Health, Catholic University in Ruzomberok, Ruzomberok, Slovakia
- 700 1_
- $a Lejavová, Katarína, $u CEEOR spol. s.r.o, Prague, Czech Republic $d 1987- $7 xx0326522
- 700 1_
- $a Rybář, Marian $u Department of Biomedical Technology, Czech Technical University in Prague Faculty of Biomedical Engineering, Kladno, Czech Republic
- 700 1_
- $a Rožánek, Martin $u Department of Biomedical Technology, Czech Technical University in Prague Faculty of Biomedical Engineering, Kladno, Czech Republic
- 700 1_
- $a Sedlák, Vratislav $u Department of Respiratory Medicine, Fakultní Nemocnice Hradec Králové, Hradec Králové, Czech Republic vratislav.sedlak@fnhk.cz
- 773 0_
- $w MED00214731 $t BMJ open respiratory research $x 2052-4439 $g Roč. 11, č. 1 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38184317 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20241127145551 $b ABA008
- 999 __
- $a ok $b bmc $g 2081559 $s 1217407
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 11 $c 1 $e 20240106 $i 2052-4439 $m BMJ open respiratory research $n BMJ Open Respir Res $x MED00214731
- LZP __
- $a Pubmed-20240412